Local thermal ablative therapies for extracranial oligometastatic disease of non-small-cell lung cancer

被引:2
|
作者
Kong, Yongmei [1 ,2 ,3 ]
Xu, Hui [1 ,2 ,3 ]
Huang, Yahan [1 ,2 ,3 ]
Wei, Zhigang [1 ,2 ]
Ye, Xin [1 ,2 ]
机构
[1] Shandong First Med Univ, Affiliated Hosp 1, Dept Oncol, Jinan 250000, Shandong, Peoples R China
[2] Shandong Prov Qianfoshan Hosp, Shandong Lung Canc Inst, Shandong Key Lab Rheumat Dis & Translat Med, Jinan 250000, Shandong, Peoples R China
[3] Shandong First Med Univ, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
extracranial; non-small cell lung cancer; oligometastatic diseases; thermal ablation; RADIOFREQUENCY ABLATION; MICROWAVE ABLATION; CLASSIFICATION; RADIOTHERAPY; METASTASIS; OUTCOMES; TUMOR; CHEMOTHERAPY; METAANALYSIS; MULTICENTER;
D O I
10.1111/ajco.13766
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Clinically, 40-50% of patients with NSCLC are found to have systemic metastasis at the initial diagnosis. Meanwhile, 30-75% of patients with lung cancer who have undergone radical surgical resection have local recurrence and distant metastases. However, not all distant metastases are multiple, and some are potentially curable. In this study, among the patients with NSCLC having distant organ metastasis, approximately 7% showed extrapulmonary solitary metastasis and remained in this relatively stable state for a long time. This form of metastasis is known as NSCLC oligometastases. This review describes the concept and classification of oligometastases, as well as the local treatment and prognosis of extracranial oligometastases.
引用
收藏
页码:3 / 8
页数:6
相关论文
共 50 条
  • [21] Antiangiogenic therapies in non-small-cell lung cancer
    Alshangiti, A.
    Chandhoke, G.
    Ellis, P. M.
    CURRENT ONCOLOGY, 2018, 25 : S45 - S58
  • [22] Emerging therapies in non-small-cell lung cancer
    Khuri, FR
    Herbst, RS
    Fossella, FV
    ANNALS OF ONCOLOGY, 2001, 12 (06) : 739 - 744
  • [23] Oligometastatic non-small-cell lung cancer: current treatment strategies
    Richard, Patrick J.
    Rengan, Ramesh
    LUNG CANCER-TARGETS AND THERAPY, 2016, 7 : 129 - 140
  • [24] Role of local ablative treatment in oligometastatic non-small cell lung cancer: a meta-analysis
    Rim, Chai Hong
    Cho, Won Kyung
    Park, Sunmin
    Yoon, Won Sup
    Yang, Dae Sik
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (04) : 1006 - 1014
  • [25] Robot-assisted extracranial stereotactic radiotherapy of adrenal metastases with the CyberKnife in oligometastatic non-small-cell lung cancer
    Celik, E.
    Semrau, R.
    Baus, W.
    Marnitz-Schulze, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S128 - S128
  • [26] Local therapy combined with chemotherapy versus chemotherapy for postoperative oligometastatic non-small-cell lung cancer
    Shang, Shuheng
    Wang, Linlin
    Su, Yi
    Li, Butuo
    Guo, Meiying
    Zhu, Zhaofeng
    Sun, Xindong
    Yu, Jinming
    FUTURE ONCOLOGY, 2019, 15 (14) : 1593 - 1603
  • [27] Oligometastatic disease of non-small cell lung cancer
    Schmid, Severin
    Passlick, Bernward
    Stuschke, Martin
    Griesinger, Frank
    ONKOLOGE, 2018, 24 (12): : 992 - 1002
  • [28] Emerging antiangiogenic therapies for non-small-cell lung cancer
    Blakely, Collin
    Jahan, Thierry
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (10) : 1607 - 1618
  • [29] Targeted therapies and immunotherapy in non-small-cell lung cancer
    Cortinovis, D.
    Abbate, M.
    Bidoli, P.
    Capici, S.
    Canova, S.
    ECANCERMEDICALSCIENCE, 2016, 10
  • [30] Radiotherapy and targeted therapies in non-small-cell lung cancer
    Girard, N.
    Mornex, F.
    BULLETIN DU CANCER, 2009, 96 (03) : 311 - 319